7 found
Order:
Disambiguations
Oonagh Corrigan [6]Oonagh P. Corrigan [4]
See also
  1.  94
    What's in a Name? Subjects, Volunteers, Participants and Activists in Clinical Research.Oonagh Corrigan & Richard Tutton - 2006 - Clinical Ethics 1 (2):101-104.
    The term research subject has traditionally been the preferred term in professional guidelines and academic literature to describe a patient or an individual taking part in biomedical research. In recent years, however, there has been a steady shift away from the use of the term 'research subject' in favour of 'research participant' when referring to individuals who take part by providing data to various kinds of biomedical and epidemiological research. This article critically examines this shift, reflecting on the different meanings (...)
    Direct download (7 more)  
     
    Export citation  
     
    Bookmark   6 citations  
  2.  20
    Towards a Moral Ecology of Pharmacological Cognitive Enhancement in British Universities.Meghana Kasturi Vagwala, Aude Bicquelet, Gabija Didziokaite, Ross Coomber, Oonagh Corrigan & Ilina Singh - 2017 - Neuroethics 10 (3):389-403.
    Few empirical studies in the UK have examined the complex social patterns and values behind quantitative estimates of the prevalence of pharmacological cognitive enhancement. We conducted a qualitative investigation of the social dynamics and moral attitudes that shape PCE practices among university students in two major metropolitan areas in the UK. Our thematic analysis of eight focus groups suggests a moral ecology that operates within the social infrastructure of the university. We find that PCE resilience among UK university students is (...)
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark   1 citation  
  3. The Limits of Consent: A Socio-Ethical Approach to Human Subject Research in Medicine.Oonagh Corrigan (ed.) - 2009 - Oxford University Press.
    Since its inception as an international requirement to protect patients and healthy volunteers taking part in medical research, informed consent has become the primary consideration in research ethics. Despite the ubiquity of consent, however, scholars have begun to question its adequacy for contemporary biomedical research. This book explores this issue, reviewing the application of consent to genetic research, clinical trials, and research involving vulnerable populations. For example, in genetic research, information obtained from an autonomous research participant may have significant bearing (...)
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark   2 citations  
  4.  51
    Pharmacogenetics: The Bioethical Problem of DNA Investment Banking.Oonagh P. Corrigan & Bryn Williams-Jones - 2006 - Studies in History and Philosophy of Science Part C: Studies in History and Philosophy of Biological and Biomedical Sciences 37 (3):550-565.
    Concern about the ethics of clinical drug trials research on patients and healthy volunteers has been the subject of significant ethical analysis and policy development—protocols are reviewed by Research Ethics Committees and subjects are protected by informed consent procedures. More recently attention has begun to be focused on DNA banking for clinical and pharmacogenetics research. It is, however, surprising how little attention has been paid to the commercial nature of such research, or the unique issues that present when subjects are (...)
    Direct download (4 more)  
     
    Export citation  
     
    Bookmark   1 citation  
  5.  1
    Pharmacogenetics: The Bioethical Problem of DNA Investment Banking.Oonagh P. Corrigan & Bryn Williams-Jones - 2004 - Studies in History and Philosophy of Biological and Biomedical Sciences 37 (3):550-565.
    Direct download  
     
    Export citation  
     
    Bookmark   1 citation  
  6. ‘First in Man’: The Politics and Ethics of Women in Clinical Drug Trials.Oonagh P. Corrigan - 2002 - Feminist Review 72 (1):40-52.
    Within the world of pharmacology, the male body has traditionally been taken as the biological norm. Coupled with this, concern about danger to the unborn foetus has meant that, until very recently, ‘women of childbearing potential’ were routinely excluded from most of the early phases of clinical drug testing. Consequently, most drugs tested during Phase I trials were initially carried out on healthy male volunteers. During subsequent phases when drugs were tested on patients, women remained largely under-represented. As a result, (...)
    No categories
    Direct download  
     
    Export citation  
     
    Bookmark   2 citations  
  7.  33
    Pharmacogenetics: The Bioethical Problem of DNA Investment Banking.Oonagh P. Corrigan & Bryn Williams-Jones - 2006 - Studies in History and Philosophy of Science Part C: Studies in History and Philosophy of Biological and Biomedical Sciences 37 (3):550-565.